Nanjing, China

Hai Chen

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Jiangsu Kanion Pharmaceutical Co., Ltd., Xintrum Pharmaceuticals, Ltd.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hai Chen. Retrieved from https://idiyas.com/inventor/hai-chen-o3zgld15

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hai Chen

Introduction

Hai Chen is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of gene combinations that enhance the expression of recombinant human nerve growth factor (rhNGF). His work has the potential to impact therapeutic approaches for nerve-related conditions.

Latest Patents

Hai Chen holds a patent for a gene combination capable of high-efficiency expression of recombinant human nerve growth factor. This innovative gene combination optimizes gene expression regulation components, leading to enhanced expression of rhNGF. Experimental results demonstrate that this gene combination achieves high-efficiency expression of rhNGF with natural activity in a eukaryotic expression system. He has 1 patent to his name.

Career Highlights

Currently, Hai Chen is associated with Xintrum Pharmaceuticals, Ltd., where he continues to advance his research in biotechnology. His work focuses on optimizing gene expression for therapeutic applications, showcasing his commitment to innovation in the field.

Collaborations

Hai Chen collaborates with notable colleagues, including Hongliang Sun and Yi Zhang. Their combined expertise contributes to the advancement of their research projects and the development of new biotechnological solutions.

Conclusion

Hai Chen's contributions to the field of biotechnology, particularly through his patent on gene combinations for rhNGF expression, highlight his role as an innovative inventor. His work at Xintrum Pharmaceuticals, along with his collaborations, positions him as a key figure in advancing therapeutic applications in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…